Transpulmonary Pressure and Airway Pressure Release Ventilation (APRV).

Sponsor
Assistance Publique Hopitaux De Marseille (Other)
Overall Status
Completed
CT.gov ID
NCT02866513
Collaborator
(none)
20
1
1
12.9
1.5

Study Details

Study Description

Brief Summary

Mechanical ventilation can induce pulmonary lesions called ventilator induced lung injury (VILI). High levels of Transpulmonary pressure is one of the most important mechanism of VILI during the use of mechanical ventilation. The use of bilevel pressure ventilator modes like APRV could generate high levels of transpulmonary pressure.

The aim of this study is to evaluate the variations of transpulmonary pressure during the use of APRV by clinicians

Condition or Disease Intervention/Treatment Phase
  • Other: evaluate the variations of transpulmonary pressure during the use of APRV by clinicians.
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Incidence of High Levels of Transpulmonary Pressure During the Use of Airway Pressure Release Ventilation.
Actual Study Start Date :
Feb 1, 2016
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Mar 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Other: Patient mechanically ventilated with APRV mode

Other: evaluate the variations of transpulmonary pressure during the use of APRV by clinicians.

Outcome Measures

Primary Outcome Measures

  1. Transpulmonary pressure [24 hours]

    Measurement of transpulmonary pressure needs the measurement of oesophageal pressure with a specific nasogastric tube. This measurement is now available in routine in few mechanical ventilators in intensive care units (eg: AVEA Ventilator. Vyasys HealthCare). Transpulmonary pressure is the difference between airway pressure and oesophageal pressure and it is now easy to obtain and monitor at the bedside with these ventilators. It is also possible to record the value furthermore than 24 hours.

Secondary Outcome Measures

  1. Maximal value of transpulmonary pressure [24 hours]

    Value of tidal volume > 8 ml/kg

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult

  • Patient mechanically ventilated for more than 48 H for acute respiratory failure

  • Decision to use of the APRV mode by clinicians in charge of the patient

Exclusion Criteria:
  • Contraindication for the use of a nasogastric tube

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assistance Publique Hôpitaux de Marseille hôpital de la Timone Marseille France 13354

Sponsors and Collaborators

  • Assistance Publique Hopitaux De Marseille

Investigators

  • Study Director: Urielle DESALBRES, Assistance Publique Hôpitaux de Marseille

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier:
NCT02866513
Other Study ID Numbers:
  • 2015-19
First Posted:
Aug 15, 2016
Last Update Posted:
Nov 14, 2017
Last Verified:
Aug 1, 2016

Study Results

No Results Posted as of Nov 14, 2017